Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
DKP-21103 by Dongkwang Pharma for Gastric Ulcers: Likelihood of Approval
DKP-21103 is under clinical development by Dongkwang Pharma and currently in Phase I for Gastric Ulcers. According to GlobalData, Phase...
Data Insights
DKP-21103 by Dongkwang Pharma for Duodenal Ulcer: Likelihood of Approval
DKP-21103 is under clinical development by Dongkwang Pharma and currently in Phase I for Duodenal Ulcer. According to GlobalData, Phase...